Comparison Between the SBK Microkeratome Versus Femtosecond Laser in Flap Creation During LASIK Surgery for Myopia

Sponsor
Kasr El Aini Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05406973
Collaborator
Eyecare Center (Other)
60
1
1
7
8.6

Study Details

Study Description

Brief Summary

LASIK is the most commonly performed refractive surgery worldwide. It has been shown to be safe and effective procedure with predictable results over long term follow ups. With the advancement of technology, sub-Bowman keratomileusis allows thin flap of approximately 100 microns thickness thus preserving thicker stromal bed as compared to conventional LASIK. The femtosecond laser corneal flap has th advantage of producing a flap of uniform thickness, adjustable flap diameter, relatively few complications. The disadvantages of this procedure is the high cost of surgery, development of bubbles in the corneal layer and anterior chamber which may affect pupil trackingduring the procedure. Despite the emergence of femtosecond laser-assisted flap creation, mechanical microkeratomes remain the preferred choice in the majority of developing countries. Recent studies have shown that SBK corneal flap has the same advantages as femtosecond laser flap regarding flap uniformity, regularity, and accuracy with less suction time and cost, but with its specific complications as well.

Condition or Disease Intervention/Treatment Phase
  • Device: SBK microkeratome versus femtosecond laser in flap creation
N/A

Detailed Description

It is a prospective comparative non randomized interventional clinical study

Primary outcomes of this study include:
  1. Comparison between the SBK microkeratome versus Femtosecond laser in flap creation during LASIK surgery for myopia using anterior segment OCT (AS-OCT) 1 month after surgery in each group of patients.

  2. Measuring corneal flap diameter using (AS-OCT)

Secondary outcomes:
  1. Measuring uncorrected and best corrected visual acuity after 1 day, 1 week, 1 month postoperative.

  2. Recording any related complications in each group.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison Between the SBK Microkeratome Versus Femtosecond Laser in Flap Creation During LASIK Surgery for Myopia
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: sbk microkeratome and femtosecond laser

Comparative non randomized Interventional clinical study between SBK microkeratome versus femtosecond laser in flap creation during LASIK surgery for myopia

Device: SBK microkeratome versus femtosecond laser in flap creation
prospective comparative non randomized interventional clinical study

Outcome Measures

Primary Outcome Measures

  1. flap thickness accuracy [1 month post operative]

    comparison between the accuracy of the SBK microkeratome versus Femtosecond laser in flap creation during LASIK surgery for myopia, 1 month after surgery using anterior segment OCT

Secondary Outcome Measures

  1. Visual Acuity measurment [1day, 1 week, 1 month after surgery]

    measuring UCVA and BCVA

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Myopes (from -1 to -9), with astigmatism up to -4, normal corneal topography, central corneal thickness (CCT) more than 500 microns, and stable refraction for at least 12 months.
Exclusion Criteria:
  • CCT less than 500 microns, any ocular pathologies, one eyed patients, history of systemic disease, intraoperative complications, and abnormal corneal topography.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eye Care Center Maadi Cairo Egypt

Sponsors and Collaborators

  • Kasr El Aini Hospital
  • Eyecare Center

Investigators

  • Principal Investigator: Yehia Salah El Din, MD, Professor of Ophthalmology, Kasr Al Aini

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mona Medhat, Ophthalmologist, Kasr El Aini Hospital
ClinicalTrials.gov Identifier:
NCT05406973
Other Study ID Numbers:
  • Kasr AlAini Hospital
First Posted:
Jun 7, 2022
Last Update Posted:
Jun 7, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mona Medhat, Ophthalmologist, Kasr El Aini Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 7, 2022